Atossa Therapeutics
ATOS
#9237
Rank
ยฃ77.44 M
Marketcap
ยฃ0.60
Share price
5.24%
Change (1 day)
-37.35%
Change (1 year)

Atossa Therapeutics (ATOS) - Net assets

Net assets on the balance sheet as of June 2025 : ยฃ43.27 Million

According to Atossa Therapeutics's latest financial reports the company has ยฃ43.27 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Atossa Therapeutics - Net assets on balance sheet (from 2010 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$ยฃ56.95 M-20.27%
2023-12-31$ยฃ71.44 M-26.73%
2022-12-31$ยฃ97.5 M-4.72%
2021-12-31$ยฃ0.10 B413.43%
2020-12-31$ยฃ19.93 M98.66%
2019-12-31$ยฃ10.03 M44.64%
2018-12-31$ยฃ6.93 M35.11%
2017-12-31$ยฃ5.13 M104.54%
2016-12-31$ยฃ2.51 M-0.59%
2015-12-31$ยฃ2.52 M-58.61%
2014-12-31$ยฃ6.1 M-5.08%
2013-12-31$ยฃ6.42 M100.72%
2012-12-31$ยฃ3.2 M219.1%
2011-12-31$ยฃ1 M-281.85%
2010-12-31$-ยฃ0.56 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ59.46 B 137,307.05%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
ยฃ6.53 B 15,001.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
ยฃ5.53 B 12,684.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
ยฃ32.55 M-24.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
ยฃ0.62 B 1,352.97%๐Ÿ‡บ๐Ÿ‡ธ USA